Brief: Adhera Therapeutics Announces CEO, Senior Management Changes, Plans For Nasdaq Uplist
19/09/2022 14:34
Sept 19 (Reuters) - Adhera Therapeutics Inc ATRX.PK :
* ADHERA THERAPEUTICS ANNOUNCES CEO, SENIOR MANAGEMENT
CHANGES,
PLANS FOR NASDAQ UPLIST
* ADHERA THERAPEUTICS ANNOUNCES CEO, SENIOR MANAGEMENT
CHANGES,
PLANS FOR NASDAQ UPLIST
* ADHERA THERAPEUTICS INC - APPOINTED ZAHED SUBHAN AS CHIEF
EXECUTIVE OFFICER OF ADHERA THERAPEUTICS, EFFECTIVE SEPTEMBER
30, 2022
* ADHERA THERAPEUTICS INC - ANDREW "AL" KUCHARCHUK, CURRENT
CHIEF
EXECUTIVE OFFICER, WILL CONTINUE TO HOLD POSITION UNTIL
SEPTEMBER 30, 2022
Source text for Eikon: ID:nGNX550QKG
Further company coverage: ATRX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adhera Therapeutics
See all newsBrief: Adhera Therapeutics Says Melior Pharmaceuticals II Terminates License Deal With Respect To MLR-1019
Brief: Adhera Therapeutics Announces CEO, Senior Management Changes, Plans For Nasdaq Uplist
Brief: Adhera Therapeutics Signs Letter Of Intent With Melior Pharmaceuticals Ii To Acquire A New Class Of Drug For Parkinson’S Disease
Ontario to begin offering second doses of COVID-19 vaccines
Brief: Adhera Therapeutics Inc Determined That Co Would Terminate Its Current Business Operations